ELVN
Enliven Therapeutics Inc.
45.20$
-2.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | 0.00 | 0.00 | – | – | |
| 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | 0.00 | 0.00 | – | – | |
| 0.48 | 0.44 | 0.47 | 0.39 | 0.44 | 0.42 | 0.50 | 0.41 | 0.29 | 0.37 | 0.33 | 0.44 | 1.35 | |
| 0.08 | 0.12 | 0.14 | 0.12 | 0.12 | 0.12 | 0.14 | 0.14 | 0.11 | 0.23 | 0.11 | 0.12 | 0.53 | |
| 0.59 | 0.55 | 0.62 | 0.51 | 0.56 | 0.54 | 0.63 | 0.55 | 0.40 | 0.60 | 0.44 | 0.56 | 1.88 | |
| -0.59 | -0.55 | -0.62 | -0.51 | -0.56 | -0.54 | -0.63 | -0.55 | -0.40 | -0.61 | -0.44 | -0.56 | -1.88 | |
| – | 0.04 | – | – | – | – | – | – | – | – | – | – | – | |
| -0.51 | -0.47 | -0.54 | -0.41 | -0.48 | -0.46 | -0.57 | -0.49 | -0.32 | -0.52 | -0.38 | -0.49 | -1.60 | |
| -0.09 | 0.13 | 0.00 | 0.00 | – | -0.01 | – | – | – | – | – | – | – | |
| -0.51 | -0.47 | -0.54 | -0.41 | -0.48 | -0.46 | -0.57 | -0.49 | -0.32 | -0.52 | -0.38 | -0.49 | -1.60 | |
| -0.50 | -0.47 | -0.54 | -0.41 | -0.48 | -0.46 | -0.57 | -0.48 | -0.32 | -0.52 | -0.38 | -0.49 | -1.60 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.